1. Ni, Haifeng, Liang, Chengxian, Zhou, Zhen, Shang, Haiqiong, Yu, Xiaoyu. 2023. METTL13 promotes nasopharyngeal carcinoma progression through regulating the ZEB1/TPT1 axis. In The journal of gene medicine, 25, e3476. doi:10.1002/jgm.3476. https://pubmed.ncbi.nlm.nih.gov/36735630/
2. Liu, Zhuonan, Sun, Tianshui, Piao, Chiyuan, Zhang, Zhe, Kong, Chuize. 2021. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression. In Journal of translational medicine, 19, 209. doi:10.1186/s12967-021-02879-2. https://pubmed.ncbi.nlm.nih.gov/33985542/
3. Zhang, Zhe, Zhang, Guojun, Kong, Chuize, Dong, Xiao, Man, Xiaojun. 2016. METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion. In Scientific reports, 6, 19261. doi:10.1038/srep19261. https://pubmed.ncbi.nlm.nih.gov/26763933/
4. Yousaf, Rizwan, Ahmed, Zubair M, Giese, Arnaud Pj, Friedman, Thomas B, Riazuddin, Saima. 2018. Modifier variant of METTL13 suppresses human GAB1-associated profound deafness. In The Journal of clinical investigation, 128, 1509-1522. doi:10.1172/JCI97350. https://pubmed.ncbi.nlm.nih.gov/29408807/
5. Li, Lei, Zheng, Yin-Li, Jiang, Chen, Xie, Dan, Guan, Xin-Yuan. 2019. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma. In Cell death and differentiation, 26, 2268-2283. doi:10.1038/s41418-019-0301-1. https://pubmed.ncbi.nlm.nih.gov/30778199/
6. Wen, Yuanzhang, Xu, Jiwei, Zhou, Huancheng, Liu, Wanwei. . Diagnostic and Prognostic Value of Methyltransferase Like 13 in Hepatocellular Carcinoma Based on Bioinformatics Analysis. In The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 35, 385-390. doi:10.5152/tjg.2024.22878. https://pubmed.ncbi.nlm.nih.gov/39128086/
智鼠故事 
